Caricamento...
Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
Ruxolitinib-associated acute respiratory distress has rarely been reported, mostly due to discontinuation of treatment. Herein we report a 58-year-old male patient with primary myelofibrosis who presented with malaise and dyspnea 15 days after initiation of the treatment. The patient was diagnosed a...
Salvato in:
| Pubblicato in: | Respir Med Case Rep |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5608559/ https://ncbi.nlm.nih.gov/pubmed/28970999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.09.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|